Late-Onset Treatment Study Extension Protocol

Conditions

• Pompe Disease (Late-Onset)
• Glycogen Storage Disease Type II (GSD-II)
• Glycogenesis Type II
• Acid Maltase Deficiency (AMD)

Interventions

• BIOLOGICAL: alglucosidase alfa

Sponsor

Genzyme, a Sanofi Company